REQUEST A DEMO
Total
USD $0.00
Search more companies

Eamon Drugs Private Limited (India)

Main Activities: Synthetic Dye and Pigment Manufacturing
Full name: Eamon Drugs Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Eamon Drugs Private Limited is an unlisted company, incorporated on 04/09/1985. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24114MP1985PTC003021 and registration number is 003021. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
104-A-2 105 A-1 Sect E Sanwer Road
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Eamon Drugs Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Eamon Drugs Private Limited report to view the information.
Outstanding Shares:
Purchase the Eamon Drugs Private Limited report to view the information.
Registered Capital:
Purchase the Eamon Drugs Private Limited report to view the information.
Incorporation Date:
September 04, 1985
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Eamon Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
20.53%
Total operating revenue
20.53%
Operating profit (EBIT)
158.35%
EBITDA
83.94%
Net Profit (Loss) for the Period
161.31%
Total assets
26.73%
Total equity
34.67%
Operating Profit Margin (ROS)
1.74%
Net Profit Margin
1.31%
Return on Equity (ROE)
12.47%
Debt to Equity Ratio
-55.4%
Quick Ratio
-0.31%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?